CD8A and COVID-19: However, COVID-19+ patients (both asymptomatic and symptomatic ones) exhibited higher proportions of cells co-expressing TOX and Eomes within PD-1+ non-naive CD8+ compared with patients at recovery or controls (Fig. S8E, left panel).